Emmanuel Katsanis

27PUBLICATIONS
71CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Transplantation immunologyCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples theory of change models for healthHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jun 12, 2026
Blinatumomab bypasses CD28 blockade to sustain T-cell cytotoxicity and improve survival in a xenograft B-ALL model.

|May 13, 2026
Post-Transplant Bendamustine as a Platform for Immune Modulation After Allogeneic Hematopoietic Cell Transplantation.

|Mar 14, 2026
TIGIT Blockade Potentiates the Anti-Leukemic Activity of Exercise-Mobilized Donor Lymphocytes and Expanded γδ T-Cells.

Grace M McKenzie, Josie Voss, Emmanuel Katsanis

|Jan 15, 2026
Exercise-mobilized lymphocytes enhance the function of cytokine-induced memory-like NK cells against myeloid leukemia.

Helena Batatinha, Angella M Valenzuela, Dimitrios Filioglou

|Sep 13, 2025
Exercise Delays Human Leukemia Progression and Mitigates Graft-Versus-Host Disease After Donor Lymphocyte Infusion in Xenogeneic Mice.

Helena Batatinha, Nicole A Peña, Giovannah A Hoskin

|Jun 13, 2025
A Triple Oral Combination of Bendamustine, Acalabrutinib, and Venetoclax Demonstrates Efficacy Against Mantle Cell Lymphoma In Vitro and In Vivo.

Dimitrios Filioglou, Nina Santa-Cruz, Geovana S F Leite

Pageof 5

Frequent Collaborators

10 joint publications

Richard J Simpson

4 joint publications

Forrest L Baker

3 joint publications

Dimitrios Filioglou

3 joint publications

Helena Batatinha